- Home
- BWEN vs GDTC Comparison
BWEN vs GDTC Comparison
Compare BWEN & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- GDTC
- Stock Information
- Founded
- BWEN N/A
- GDTC 2018
- Country
- BWEN United States
- GDTC Singapore
- Employees
- BWEN N/A
- GDTC N/A
- Industry
- BWEN Industrial Machinery/Components
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- GDTC Health Care
- Exchange
- BWEN Nasdaq
- GDTC Nasdaq
- Market Cap
- BWEN 32.1M
- GDTC 29.4M
- IPO Year
- BWEN N/A
- GDTC 2023
- Fundamental
- Price
- BWEN $1.68
- GDTC $2.46
- Analyst Decision
- BWEN Strong Buy
- GDTC Buy
- Analyst Count
- BWEN 3
- GDTC 1
- Target Price
- BWEN $4.50
- GDTC $5.00
- AVG Volume (30 Days)
- BWEN 94.0K
- GDTC 32.8K
- Earning Date
- BWEN 05-13-2025
- GDTC 01-01-0001
- Dividend Yield
- BWEN N/A
- GDTC N/A
- EPS Growth
- BWEN N/A
- GDTC N/A
- EPS
- BWEN 0.05
- GDTC N/A
- Revenue
- BWEN $143,136,000.00
- GDTC $330,254.00
- Revenue This Year
- BWEN $8.78
- GDTC $14.71
- Revenue Next Year
- BWEN $10.05
- GDTC N/A
- P/E Ratio
- BWEN $33.60
- GDTC N/A
- Revenue Growth
- BWEN N/A
- GDTC N/A
- 52 Week Low
- BWEN $1.41
- GDTC $1.20
- 52 Week High
- BWEN $4.65
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- BWEN 63.32
- GDTC 49.89
- Support Level
- BWEN $1.51
- GDTC $2.26
- Resistance Level
- BWEN $1.68
- GDTC $2.53
- Average True Range (ATR)
- BWEN 0.08
- GDTC 0.25
- MACD
- BWEN 0.02
- GDTC 0.01
- Stochastic Oscillator
- BWEN 96.15
- GDTC 55.38
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.